Announcement: AMOR welcomes the new Editor-in-Chief

Julie Earl completed her PhD at the University of Liverpool, UK and her postdoctoral studies at the University of Liverpool and the Spanish Cancer Research Center (CNIO) in Madrid, Spain. She is a senior researcher in the Medical Oncology department of the university hospital Ramón y Cajal, Madrid, Spain since 2011 and specializes in cancer genetics and tumor biomarkers, particularly in digestive cancers. She is the coordinator of the Spanish familial pancreatic cancer registry and also the coordinator of the BEAMing facility within the institute. The lines of research include the genetics of familial pancreatic cancer and the use of the liquid biopsy for the identification and validation of tumor biomarkers. The main focus are gastrointestinal cancers such as colon, pancreas and gastric but also lung and glioblastoma. Currently, she and her colleagues are performing whole exome sequencing to identify novel genes associated with familial cancer and also validating developing liquid biopsy based tumor markers as prognostic and diagnostic tools. This includes Circulating Tumor Cells (CTC) detection and circulating free tumor DNA detection (cftDNA) in plasma. More recently, she is investigating the use of ultrasounds as a complementary strategy for the treatment of tumors with a high stroma content such as pancreatic tumors. She has published more than 25 papers and currently actively participates in several national and international projects in oncology research.

As we extend our warmest welcome to Dr. Julie Earl, the journal would also like to acknowledge Prof. Dr. Kwong-Kwok Wong , our immediate past EIC, for his service to the journal since its inception. Under Dr. Julie Earl 's leadership, we look forward to improving the quality of AMOR and having a greater presence in international medical literature.